Part 5/8:
Moreover, the acute care costs associated with the procedures amplify the financial burden on both patients and health systems. As patients often require hospitalization while receiving CAR-T treatment, the overall expense can escalate far beyond the base price tag, further complicating reimbursement negotiations with public and private payers.